NIH Director’s Transformative Research Awards (R01 Clinical Trial Optional)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The NIH Director’s Transformative Research Award supports innovative and unconventional research projects led by individual scientists or teams that have the potential to create new scientific paradigms, develop transformative technologies, or introduce improved clinical approaches. It is open to applications across all biomedical sciences without requiring preliminary data. Proposals must strongly demonstrate the potential for significant broad impact relevant to the NIH’s mission based on sound scientific logic. This award is part of the NIH Common Fund's High-Risk, High-Reward Research Program, which encourages bold and groundbreaking research initiatives. The contract opportunity is forecasted and titled "NIH Director’s Transformative Research Awards (R01 Clinical Trial Optional)" and is managed by the National Institutes of Health within the Department of Health and Human Services. While specific location details are not provided, interested applicants can direct queries to the designated program contact via email. The award aims to promote high-impact research that can substantially advance biomedical knowledge and health outcomes. Further information and application details are accessible through the provided grants.gov link.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The NIH Director’s Transformative Research Award supports individual scientists or groups of scientists proposing bold, groundbreaking, exceptionally innovative, original, and/or unconventional research with the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies. Applications in any area within the biomedical sciences are welcome. No preliminary data are required. Projects must clearly demonstrate, based on the strength of the logic, a compelling potential to produce a major impact in a broad area of relevance to the NIH. The NIH Director’s Transformative Research Award is a component of the High-Risk, High-Reward Research (HRHR) Program of the NIH Common Fund.
